Medication info
Alfosent Tablet (Cholin Alfoscerate)

Alfosent Tablet (Cholin Alfoscerate)

Prescription medicationTabletOral
Ingredient · strength
Choline Alfoscerate›400mg / 1 tablet
Manufacturer / importer
Nexfarm Korea Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablet
Packaging
Bottle packaging - 90 tablets/bottle, PTP packaging - 90 tablets/box [10 tablets/PTP X 9]
Approval status
Active

MFDS item code 201604661 · Approved 2016.07.28 · Insurance code 662503520

Summary

Main use
Improvement of symptoms of cerebrovascular deficits and organic brain syndrome (including memory impairment)
Who takes it
Adults
Adult dose
Administer 400 mg of choline alfoscerate orally per dose, 2~3 times daily. The dose may be adjusted as appropriate according to symptoms.

Ingredients

Manufacturer
Nexfarm Korea Co., Ltd.

Efficacy & effects

Improvement of symptoms of cerebrovascular deficits and organic brain syndrome (including memory impairment)

  • Memory impairment
  • confusion
  • disorientation
  • decreased motivation and spontaneity
  • reduced concentration
View approved original text

This medication is used for secondary symptoms caused by cerebrovascular deficits and degenerative or progressive organic mental syndromes. It helps improve symptoms such as memory impairment, confusion, disorientation due to decreased motivation and spontaneity, and reduced concentration. It effectively alleviates these symptoms, contributing to the enhancement of the patient's daily living abilities. Clinical trial results in South Korea support this. Therefore, this drug is used to treat symptoms associated with cognitive decline.

How to take

Adult dose

Administer 400 mg of choline alfoscerate orally per dose, 2~3 times daily. The dose may be adjusted as appropriate according to symptoms.

Precautions

This medication should not be used by individuals who are allergic to this drug or its components. Additionally, women who are pregnant or may become pregnant should not take this medication. Nausea may occur when taking this medication, which is due to its effect on dopamine action in the brain. If such symptoms occur, the dosage of the medication should be reduced. It may affect the gastrointestinal tract and can cause gastritis or other gastrointestinal disorders. It may impact mental or neurological functions leading to drowsiness, insomnia, irritability, nervousness, convulsions, and excessive motor activity. This medication should be kept out of the reach of children. Additionally, transferring the medication to another container may lead to accidents and deterioration in the quality of the drug, so it is advisable to store it in its original container.

Side effects

  • nausea
  • gastritis
  • gastric disease
  • drowsiness
  • insomnia
  • aggression
  • irritability
  • convulsions
  • hyperactivity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid exposure to air or moisture, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablet

Package unit

Bottle packaging - 90 tablets/bottle, PTP packaging - 90 tablets/box [10 tablets/PTP X 9]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.